Specialized news

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1398
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 605764480_1275897227908799_5804145375518154194_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-12-29
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-29 08:29:14
            [updated_time] => 2026-01-15 09:52:40
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Congratulations-on-the-successful-December-prenatal-class-The-journey-to-happy-motherhood-of-Andrology-and-Fertility-hospital-of-Hanoi
            [title] => Congratulations on the successful December prenatal class – The journey to happy motherhood of Andrology and Fertility hospital of Hanoi
            [description] => On the morning of December 27, 2025, at the 5th Floor Hall – Building A, Andrology and Fertility hospital of Hanoi, the program “Prenatal Class – The Journey to Happy Motherhood” was successfully held, leaving many deep emotions and meaningful values for all expectant mothers and their families in attendance. The program was not only a simple medical knowledge-sharing session but also a journey of spreading love, understanding, and strong faith for families preparing to welcome their little angels.
            [content] => 
Prenatal class – A strong foundation for the journey of motherhood
Pregnancy and childbirth are sacred journeys, yet they are also accompanied by many worries and concerns, especially for first-time mothers or families who have experienced the long and challenging journey of infertility. Understanding this, Hanoi Andrology and Fertility Hospital, in collaboration with the Happy Home Association, organized the Prenatal Class – The Journey to Happy Motherhood with the hope of providing expectant mothers with scientific knowledge, emotional stability, and the most comprehensive preparation before their delivery day.

From early morning, the hall welcomed a large number of expectant mothers and their families, creating a warm, intimate atmosphere filled with positive energy. The enthusiastic participation of families clearly reflected the strong demand for systematic prenatal education and the trust they place in the hospital’s medical team.
Experienced doctors accompanying Parents-to-be
The program was honored to have the direct participation and sharing of experienced obstetrics and gynecology specialists from Hanoi Andrology and Fertility Hospital:
 Dr. Nguyen Thi Hong Nhung, Specialist in Obstetrics and Gynecology, and Dr. Dam Dinh Tam, Specialist in Obstetrics and Gynecology.

With solid professional expertise and years of experience accompanying thousands of childbirth cases, the doctors delivered practical, easy-to-understand, and highly relevant information. The class focused on key concerns such as physical changes during pregnancy, signs of labor, natural birth and cesarean section procedures, pain management during labor, postpartum care for both mother and baby, as well as psychological preparation for welcoming the newborn.
Beyond one-way knowledge sharing, the doctors devoted significant time to directly answering every question from expectant mothers and their families — from simple concerns about nutrition and safe exercise to deeper worries about the childbirth process — all were carefully listened to and thoroughly advised.
Providing official medical knowledge – Confidence for a safe delivery
One of the most outstanding values of the prenatal class was the provision of official medical knowledge based on professional guidelines and clinical practice. This helped expectant mothers avoid misleading and unverified information widely circulating on social media.

Through the class, mothers gained a better understanding of their own bodies, learned how to listen to changes during pregnancy, and recognized early signs that require medical attention. More importantly, with sufficient knowledge and strong psychological preparation, mothers felt much more confident and reassured when approaching childbirth — a sacred and unforgettable milestone in life.
Many participants shared that after the session, they felt more relaxed, less anxious, and more confident about the journey ahead. This is precisely the goal Hanoi Andrology and Fertility Hospital always strives for when organizing its regular prenatal classes.
A loving connection space for the whole family
Not only for expectant mothers, the prenatal class also created an opportunity for future fathers and family members to join, listen, and better understand the journey of pregnancy and childbirth. Family support is a powerful source of emotional strength, helping mothers feel more secure and happy.

The class atmosphere was open and friendly, where everyone could share their own stories, emotions, and experiences. This meaningful connection helped form a warm community where families prepared for parenthood with a proactive and positive mindset.
Eurofins GENTIS – Proud to be the accompanying sponsor
Contributing significantly to the success of the program, Eurofins GENTIS was honored to be the accompanying sponsor of the Prenatal Class – The Journey to Happy Motherhood. With the mission of providing high-quality testing solutions and healthcare services, Eurofins GENTIS continuously supports Vietnamese families in achieving safe and healthy pregnancies and childbirth.
Their companionship not only ensured a well-organized and meaningful program but also reflected a long-term commitment to maternal and child healthcare, especially during the prenatal stage — the foundation for a child’s comprehensive development in the future.
In the coming time, Eurofins GENTIS will continue accompanying the regular prenatal classes of Hanoi Andrology and Fertility Hospital, contributing to the best possible physical and emotional preparation for expectant mothers before childbirth. Because Eurofins GENTIS understands that each class is not just a knowledge-sharing session, but also a meaningful milestone that builds mothers’ confidence, strengthens family bonds, and makes the journey of parenthood gentler and happier.
The Prenatal Class – The Journey to Happy Motherhood on December 27, 2025 concluded in a warm atmosphere filled with joy and trust. The success of the program once again affirms the continuous efforts of Hanoi Andrology and Fertility Hospital in providing comprehensive care for families, along with the valuable support of partners such as Eurofins GENTIS.
We wish all expectant mothers good health, peace of mind, a fulfilling pregnancy, and a smooth, gentle delivery. May all families soon welcome their beloved babies, opening a new chapter filled with happiness and love.

            [content_more] => 
            [meta_title] => Congratulations on the successful December prenatal class – The journey to happy motherhood of Andro
            [meta_description] => On the morning of December 27, 2025, at the 5th Floor Hall – Building A, Andrology and Fertility hospital of Hanoi, the program “Prenatal Class – The Journey to Happy Motherhood” was successfully held, leaving many deep emotions and meaningful values for 
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1398
            [category_id] => 15
        )

    [1] => stdClass Object
        (
            [id] => 1397
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 299d08137c20f37eaa31.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-12-26
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-26 15:55:42
            [updated_time] => 2026-01-14 15:50:20
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-&-andrology-and-fertility-hospital-of-Hanoi-announce-research-on-recurrent-pregnancy-loss-The-role-of-multigene-sequencing-in-genetic-screening-and-counseling
            [title] => Eurofins GENTIS & andrology and fertility hospital of Hanoi announce research on recurrent pregnancy loss: The role of multigene sequencing in genetic screening and counseling
            [description] => Recently, the scientific study entitled “Recurrent Pregnancy Loss: The Role of Multigene Sequencing in Genetic Screening and Counseling,” conducted by Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility, was officially published in Issue No. 197 of the Journal of Medical Research.
            [content] => 

The study was conducted with the objective of investigating the spectrum of genetic variants detected by FertiScan™ (a test designed to identify genetic abnormalities associated with female infertility and recurrent pregnancy loss) in women with a history of recurrent miscarriage.
The study population consisted of 20 infertile women with a history of recurrent pregnancy loss (RPL). RPL was defined as two or more consecutive spontaneous miscarriages before 20 weeks of gestation at the Hanoi Hospital of Andrology and Infertility from May to August 2023.
The study indicates that recurrent miscarriage and repeated fetal loss are common challenges in assisted reproductive practice, affecting approximately 1–5% of women of reproductive age. In addition to uterine anatomical, endocrine, immunohematological, and infectious causes, genetic factors play an important role but are not easily detected by routine testing. The cause of miscarriage remains unknown in more than 50% of these cases.
Karyotype analysis and microarray testing are useful for identifying chromosomal numerical and structural abnormalities, but they remain limited in detecting single-gene causes related to oocyte development, meiosis, implantation, and early embryonic viability. Therefore, targeted molecular genetic approaches are receiving increasing attention.
In recent years, next-generation sequencing (NGS) panels have enabled simultaneous analysis of multiple genes related to female reproduction, expanding the ability to identify genetic etiologies in patients with recurrent miscarriage and fetal loss. Among these, the FertiScan™ Global Female Infertility Panel is a representative tool, covering more than 70 genes involved in key pathogenic mechanisms including premature ovarian failure and ovarian dysfunction, ovarian dysgenesis, defects in oocyte maturation, abnormal oocyte–zona pellucida–fertilization interactions, genes affecting implantation and endometrial signaling, as well as DNA repair genes associated with early embryonic lethality.
This approach not only increases the detection rate of clinically significant genetic variants but also supports personalized counseling and intervention strategies, including partner testing in autosomal recessive disorders, indications for PGT-M or PGT-SR, and prenatal genetic screening when appropriate.
In Vietnam, data on the prevalence of genetic variants in women with unexplained recurrent pregnancy loss remain limited. This gap restricts optimal prognostic counseling and personalized treatment, particularly in cases with normal karyotype results but persistent pregnancy loss.
The implementation of specialized targeted NGS panels such as FertiScan™ provides value in identifying subsets of patients carrying pathogenic or likely pathogenic variants truly associated with reproductive biological mechanisms, and in documenting variants of uncertain significance (VUS) within the Vietnamese population in order to gradually standardize variant interpretation according to the classification guidelines of the American College of Medical Genetics and Genomics (ACMG). FertiScan™ results are interpreted following ACMG/AMP (American College of Medical Genetics and Genomics/Association for Molecular Pathology) variant classification guidelines, including pathogenic (P), likely pathogenic (LP), variant of uncertain significance (VUS), and benign/likely benign. Variant classification is always considered within the specific clinical and family context to ensure individual appropriateness.
From an application perspective, FertiScan™ enhances the detection of monogenic causes in patients with recurrent pregnancy loss, particularly in cases without chromosomal abnormalities identified by karyotype or microarray. The test also supports personalized genetic counseling, including partner testing in recessive genetic conditions, recommendations for PGT-M/PGT-SR, and the development of appropriate prenatal or preconception screening plans. Furthermore, FertiScan™ demonstrates strong potential for application in genetic epidemiology research in Vietnam, contributing to the establishment of population-based variant databases, thereby improving the accuracy of variant interpretation and the quality of diagnosis, counseling, and future interventions.
These results highlight the importance of systematically integrating genetic testing into the evaluation of recurrent miscarriage and fetal loss, with multigene testing positioned within structured pre- and post-test counseling and long-term follow-up strategies.
With the mission of “Enhancing the intellectual and physical well-being of the Vietnamese people,” Eurofins GENTIS continues its collaboration with the Hanoi Hospital of Andrology and Infertility to implement high-value medical research and to further develop a comprehensive ecosystem of advanced genetic testing. Through these efforts, Eurofins GENTIS contributes to delivering modern healthcare solutions and supporting medical professionals in improving reproductive healthcare for the community.
            [content_more] => 
            [meta_title] => Eurofins GENTIS & andrology and fertility hospital of Hanoi announce research on recurrent pregnancy
            [meta_description] => Recently, the scientific study entitled “Recurrent Pregnancy Loss: The Role of Multigene Sequencing in Genetic Screening and Counseling,” conducted by Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility, was officially published in Issue N
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1397
            [category_id] => 15
        )

    [2] => stdClass Object
        (
            [id] => 1396
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 06f14a7e3e4db113e85c.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-12-26
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-26 08:41:18
            [updated_time] => 2026-01-14 15:41:21
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-&-Andrology-and-fertility-hospital-of-Hanoi-publish-research-findings-on-recurrent-pregnancy-loss-in-the-journal-of-medical-research
            [title] => Eurofins GENTIS & Andrology and fertility hospital of Hanoi publish research findings on recurrent pregnancy loss in the journal of medical research
            [description] => Recently, Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility officially published the results of their scientific study evaluating the role of multigene sequencing (NGS) — specifically the FertiScan™ panel — in identifying genetic causes in women with a history of recurrent pregnancy loss (RPL).
            [content] => 
The research findings were presented in the scientific article entitled: “Recurrent Pregnancy Loss: The Role of Multigene Sequencing in Genetic Screening and Counseling,” which was published in Journal of Medical Research, Issue No. 197, December 2025 — a prestigious journal featuring original research and review articles in basic medicine, clinical medicine, preventive medicine, public health, and medical sociology, aimed at advancing medical knowledge and practice.

The study was conducted on 20 infertile patients with a history of recurrent pregnancy loss at the Hanoi Hospital of Andrology and Infertility between May and August 2023. According to experts, recurrent miscarriage and fetal loss represent a major challenge in assisted reproduction, affecting approximately 1–5% of women of reproductive age.

In recent years, next-generation sequencing (NGS) panels have enabled simultaneous analysis of multiple genes related to female reproduction, significantly expanding the ability to identify genetic etiologies in patients with recurrent miscarriage and fetal loss.
Among these tools, the FertiScan™ Global Female Infertility Panel is particularly comprehensive, covering more than 70 genes involved in key pathogenic mechanisms, including: Premature ovarian failure and ovarian dysfunction. Ovarian dysgenesis. Oocyte maturation defects. Abnormal oocyte–zona pellucida–fertilization interactions. Genes affecting implantation and endometrial signaling. DNA repair genes associated with early embryonic lethality
In this study, researchers used the FertiScan™ Global Female Infertility Panel (70 genes) based on NGS technology to simultaneously examine coding regions and splice sites of the target genes.
Among the 20 patients, 12 cases (60%) carried ≥ 1 reproduction-related genetic variant, including: 4 patients harboring pathogenic or likely pathogenic variants (P/LP). Predominantly in the heterozygous state of autosomal recessive disorders.
A substantial proportion of detected variants were classified as variants of uncertain significance (VUS). Notably, variants were identified in genes with well-established biological roles, such as CEP250, TACR3, NOBOX, ZP1, and others.
The FertiScan™ test which identifies genetic causes of infertility and rare hereditary abnormalities associated with female infertility and recurrent miscarriage, as well as evaluates male reproductive health — significantly enhances the detection of monogenic causes in patients with RPL, particularly in cases without chromosomal abnormalities detected by karyotyping or microarray analysis.
The test also supports personalized genetic counseling, including: Partner testing in autosomal recessive conditions. Indications for PGT-M (preimplantation genetic testing for monogenic diseases). PGT-SR (preimplantation genetic testing for structural chromosomal rearrangements). Development of tailored prenatal and preconception screening strategies
Beyond its clinical value, FertiScan™ demonstrates strong potential in genetic epidemiology research in Vietnam, contributing to the establishment of population-specific variant databases and thereby improving variant interpretation, diagnostic accuracy, counseling, and future clinical interventions.
Researchers concluded that multigene testing such as FertiScan™ significantly improves the detection of underlying causes in unexplained RPL cases, particularly when integrated into comprehensive pre- and post-test counseling and long-term follow-up.
Sharing insights on the study, Dr. Pham Dinh Minh, R&D Director of Eurofins GENTIS and co-author of the publication, stated:“Publishing in the Journal of Medical Research is a long journey — from idea generation, study implementation, data analysis, manuscript preparation, submission, to rigorous peer review. Beyond scientific merit, the research must demonstrate strict methodological rigor and data integrity. We spent more than three months collecting data and over two years completing the project. The publication of this work is a source of pride for our team and opens new avenues for research in infertile women with recurrent pregnancy loss, helping realize the dream of parenthood for many couples and highlighting the immense potential of genetic applications in reproductive medicine in Vietnam.”
Through systematically conducted research and publication in prestigious scientific journals, Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility continue to reaffirm their joint commitment to advancing genetic research and its integration into clinical practice — contributing to improved diagnostic and treatment quality in assisted reproduction across Vietnam.
            [content_more] => 
            [meta_title] => Eurofins GENTIS & Andrology and fertility hospital of Hanoi publish research findings on recurrent p
            [meta_description] => Recently, Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility officially published the results of their scientific study evaluating the role of multigene sequencing (NGS) — specifically the FertiScan™ panel — in identifying genetic causes 
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1396
            [category_id] => 15
        )

    [3] => stdClass Object
        (
            [id] => 1395
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 603924137_1486168513515857_3858940485546585452_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-12-25
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-25 13:18:45
            [updated_time] => 2026-01-14 15:26:26
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-pioneers-the-deployment-of-Next-generation-sequencing-technology-MiSeq-i100-Plus-in-Vietnam
            [title] => Eurofins GENTIS pioneers the deployment of Next-Generation sequencing technology MiSeq i100 Plus in Vietnam
            [description] => Eurofins GENTIS has officially marked a major milestone by becoming the first organization in Vietnam to install and deploy the MiSeq i100 Plus system — the latest next-generation sequencing (NGS) technology from Illumina. This achievement strongly affirms Eurofins GENTIS’s long-term commitment to continuously advancing genetic diagnostic capabilities and aligning with the highest standards of modern global medicine.
            [content] => 
The MiSeq i100 Plus is Illumina’s newest benchtop sequencer — from the world’s leading brand in NGS technology. More than a conventional sequencing instrument, the MiSeq i100 Plus represents a significant leap forward in performance, speed, and accuracy, meeting the ever-growing demands of clinical and research laboratories.

Eurofins GENTIS’s pioneering adoption of this system clearly reflects its strategic, long-term investment vision to deliver the most advanced genetic testing solutions to the community.

One of the most outstanding advantages of the MiSeq i100 Plus is its exceptional sequencing speed. By leveraging advanced chemistry and an optimized workflow, the system significantly shortens run times, enabling many NGS-based tests to deliver same-day results while maintaining high accuracy and data reliability.

 This capability is particularly critical in clinical settings requiring rapid decision-making, allowing physicians to implement timely and effective treatment strategies.
In addition to speed, the MiSeq i100 Plus features a “Touch & Run” plug-and-play design, simplifying complex technical procedures. The integrated reagent cartridge minimizes manual preparation steps, thereby reducing human error and enhancing consistency between runs. With its user-friendly design and high level of automation, Eurofins GENTIS’s technical team can operate the system smoothly and reliably, while dedicating greater focus to in-depth analysis and rigorous quality control.
The system incorporates Illumina’s proprietary XLEAP-SBS™ technology, delivering superior read quality and significantly improving the accuracy and reliability of sequencing data. This allows the platform to precisely detect and analyze complex genetic variants, meeting the stringent requirements of modern genetic testing across both clinical and research applications.

With installation, technology transfer, and continuous technical support from Mitalab, Eurofins GENTIS is maximizing the capabilities of the MiSeq i100 Plus across multiple critical fields of medicine and molecular biology.
NGS enables accurate analysis of chromosomal abnormalities and pathogenic genetic variants, significantly enhancing reproductive health counseling and care, and helping many families realize their dream of parenthood.
The MiSeq i100 Plus plays a pivotal role in early detection of cancer-related genetic mutations, comprehensive tumor genomic profiling, and the development of targeted treatment regimens.
 This forms the foundation of precision medicine, where each patient receives therapies tailored to their unique genetic profile — improving treatment outcomes and quality of life.
The system expands capabilities in diagnosing rare diseases and conducting high-sensitivity microbial studies, enabling the detection of novel or hard-to-identify pathogens beyond the limits of conventional methods.
 These advancements contribute not only to clinical effectiveness but also to biomedical research and healthcare development in Vietnam.
Becoming the first organization in Vietnam to deploy the MiSeq i100 Plus once again reinforces Eurofins GENTIS’s leadership position in genetic testing and diagnostics.
 This milestone reflects not only technological achievement but also the company’s strategic vision, deep professional expertise, and long-term commitment to bringing the world’s most advanced medical technologies closer to the Vietnamese community.
Looking ahead, Eurofins GENTIS will continue making strong investments in technological infrastructure, human resources, and international collaboration — partnering with the healthcare sector to elevate diagnostic quality, advance personalized medicine, and safeguard public health.

            [content_more] => 
            [meta_title] => Eurofins GENTIS pioneers the deployment of Next-Generation sequencing technology MiSeq i100 Plus in 
            [meta_description] => Eurofins GENTIS has officially marked a major milestone by becoming the first organization in Vietnam to install and deploy the MiSeq i100 Plus system — the latest next-generation sequencing (NGS) technology from Illumina. This achievement strongly affirm
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1395
            [category_id] => 15
        )

    [4] => stdClass Object
        (
            [id] => 1393
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => dsc09793.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2025-12-18
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-18 09:02:36
            [updated_time] => 2025-12-18 11:21:18
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Preimplantation-genetic-testing-A-key-to-improving-IVF-success-and-protecting-future-generations
            [title] => Preimplantation genetic testing: A key to improving IVF success and protecting future generations
            [description] => In recent years, in vitro fertilization (IVF) has become a vital solution helping tens of thousands of Vietnamese couples realize their dream of parenthood. 
            [content] => 
Each year, approximately 50,000 IVF cycles are performed in Vietnam, making the country one of the fastest-growing IVF markets in the region. However, alongside this growth come increasingly evident challenges: how to improve success rates, reduce the number of embryo transfers, optimize treatment costs, and—most importantly—ensure the long-term birth of healthy babies. Advanced genetic solutions are playing a pivotal role, laying the foundation for modern, precise, and sustainable reproductive medicine. IVF success rates vary by center and patient age; they are commonly reported at around 40–50% in younger patient groups and decline significantly with increasing maternal age, as well as other influencing factors such as oocyte and sperm quality, endometrial conditions, and embryo quality.
Preimplantation Genetic Testing (PGT) has become one of the most important tools for enhancing the quality of IVF treatment. PGT enables genetic evaluation of embryos prior to uterine transfer, thereby supporting the selection of embryos with high implantation potential and reducing the risk of genetic abnormalities. At EUROFINS GENTIS, a comprehensive PGT testing system—including PGT-A, PGT-SR, PGT-M, PGT-NEXT, and PGT-UPGRADE—is implemented in an integrated manner, providing physicians and patients with stronger scientific evidence to select optimal embryos, minimize risks, and improve IVF success rates.
PGT-M – Protecting future generations from monogenic genetic disorders

In addition to chromosomal abnormalities, monogenic genetic disorders continue to silently affect the health and happiness of many Vietnamese families. These conditions are often detected only after birth, leading to long-term treatment burdens and significantly impacting the quality of life of families and society as a whole.
Prof. Dr. Nguyen Dinh Tao (Chairman of Hanoi Assisted Reproduction) has highlighted PGT-M at EUROFINS GENTIS as a pioneering solution in early genetic disease prevention strategies. He noted that PGT-M enables accurate detection of known disease-causing mutations identified in parents or within families, allowing for the screening and selection of unaffected embryos prior to transfer. A key strength of PGT-M at EUROFINS GENTIS lies in its closed-loop and highly individualized process, which includes in-depth genetic counseling, identification of disease-related mutations, tailored test strategy design, and embryo genetic analysis using next-generation sequencing (NGS) technology. This solution can be applied to a wide range of genetic disorders, including rare diseases, opening opportunities for healthy childbirth among high-risk couples. Beyond its clinical value in establishing pregnancies unaffected by specific inherited traits—such as known pathogenic variants carried by one or both parents—PGT-M also helps reduce long-term treatment burdens, lower societal healthcare costs, and improve overall population health.
PGT-AI – AI breakthroughs in reproductive genetics

Alongside rapid advances in digital technology, artificial intelligence (AI) and bioinformatics are driving profound changes in reproductive medicine. Beyond genetic data analysis alone, AI enables the integration of multiple data sources—such as embryo imaging, molecular biology data, and clinical factors—thereby generating more accurate predictive models of embryo implantation potential and developmental outcomes.
Speaking at the HASAM 2025 conference, Dr. Pham Dinh Minh (R&D Director, EUROFINS GENTIS) introduced a new test researched and piloted by EUROFINS GENTIS: PGT-AI (icOne)—an advanced AI algorithm certified by the FDA, enabling in-depth analysis of embryo genetic data using modern machine learning platforms. This technology overcomes limitations of traditional PGT methods and supports more precise and personalized clinical decision-making for each patient.
Dr. Minh further noted that EUROFINS GENTIS is currently the exclusive partner implementing PGT-AI (icOne) in Vietnam, marking a significant milestone in bringing world-leading medical technologies closer to domestic patients. The combination of AI, bioinformatics, and the extensive expertise of specialist teams has enhanced IVF effectiveness while optimizing treatment costs and patient experience.
International quality management systems – The foundation for PGT accuracy

In reproductive genetics, particularly PGT testing, quality management systems play a decisive role in ensuring accuracy and reliability of results, directly influencing embryo selection, IVF treatment outcomes, and the future of each family. According to Dr. Nguyen Quang Vinh (Laboratory Director, EUROFINS GENTIS): “The comprehensive quality management system at EUROFINS GENTIS is built and operated in accordance with strict international standards such as ISO 15189, CAP, and CLSI. This ensures standardization across the entire PGT testing workflow—from receiving embryo biopsy samples, DNA processing, NGS and bioinformatics data analysis, to final reporting. Rigorous control at every step not only minimizes technical errors and ensures consistency and reproducibility of results, but also enhances safety, data security, and traceability, thereby supporting more accurate clinical decision-making.”
Together with internationally accredited laboratories, strict DNA contamination control environments, and highly experienced experts, EUROFINS GENTIS maintains high reliability in PGT testing while establishing a solid foundation for implementing advanced technologies such as PGT-AI—contributing to improved IVF outcomes and strengthening the trust of IVF centers and patients nationwide.
Accompanying the journey to parenthood
Guided by science, technology, and quality, EUROFINS GENTIS not only provides advanced genetic testing services but also serves as a trusted partner to IVF centers and Vietnamese families on their journey toward parenthood. Through the application of modern genetic technologies, EUROFINS GENTIS is steadily contributing to higher IVF success rates, early prevention of genetic diseases, and the sustainable development of reproductive medicine in Vietnam.
            [content_more] => 
            [meta_title] => Preimplantation genetic testing: A key to improving IVF success and protecting future generations
            [meta_description] => Preimplantation Genetic Testing (PGT) has become one of the most important tools for enhancing the quality of IVF treatment. PGT enables genetic evaluation of embryos prior to uterine transfer, thereby supporting the selection of embryos with high implant
            [meta_keyword] => GENTIS,PGT
            [thumbnail_alt] => 
            [post_id] => 1393
            [category_id] => 15
        )

    [5] => stdClass Object
        (
            [id] => 1392
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 596067328_1263300952501760_1825096505615856739_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-11-12
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-12 15:41:15
            [updated_time] => 2025-12-22 11:35:26
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-partners-with-Hanoi-hospital-of-andrology-and-infertility-to-host-the-december-prenatal-class
            [title] => Eurofins GENTIS partners with Hanoi hospital of andrology and infertility to host the december prenatal class
            [description] => The journey of pregnancy is a sacred experience, one filled with unique emotions for every mother. It is the overwhelming joy of discovering the presence of a beloved baby, the day-by-day anticipation of feeling those first tiny movements, and at the same time, countless questions and concerns about health, nutrition, labor, and newborn care.
            [content] => 
Understanding these concerns, Eurofins GENTIS is proud to partner with the Hanoi Hospital of Andrology and Infertility (AF HANOI) to organize the Prenatal Class – The Journey to Happy Motherhood, offering expectant mothers a warm, supportive space to gain knowledge and meaningful connection.
A special space for expectant mothers – where the journey to motherhood becomes sweeter
The prenatal class is not simply a session on pregnancy knowledge; it is a place where mothers-to-be and fathers-to-be can find reassurance, support, and love. It is an opportunity for future parents to prepare a solid foundation together before welcoming their little angel.
AF HANOI and Eurofins GENTIS aim to create a gentle, friendly learning environment where every mother feels comfortable sharing her concerns and receiving guidance from leading experts in obstetrics and gynecology.

Expert participation – the highlight of the Prenatal Class
At this session, expectant mothers will have the opportunity to listen to practical and valuable professional insights from two experienced doctors:


Dr. Nguyen Thi Hong Nhung, MD – Specialist in Obstetrics & Gynecology



Dr. Dam Dinh Tam, MD – Specialist in Obstetrics & Gynecology




With many years of experience accompanying pregnant women, these experts will deliver a friendly, practical, and informative session, helping young parents better understand fetal development and the changes in the mother’s body throughout pregnancy.
Prenatal Class – The journey to happy motherhood includes a wide range of topics, such as:
Essential knowledge on prenatal care
 Mothers will be guided on appropriate nutrition, gentle exercises, proper health monitoring, warning signs to watch for, and ways to care for mental well-being to stay positive throughout the nine months and ten days of pregnancy.
Understanding labor and achieving a safe delivery
 From signs of labor and bodily changes, to proper breathing and pushing techniques, and preparing a hospital bag—everything will be explained in detail by doctors to help mothers feel more confident during this important moment.
Scientific newborn care from the very first days of life
 Caring for a newborn is always a major challenge, especially for first-time mothers. In the class, mothers will learn essential basics such as proper breastfeeding, bathing a baby, and handling common newborn issues.
Comprehensive Q&A from A to Z
 Beyond passive learning, expectant mothers can ask doctors questions directly. Any concern—no matter how small—will be answered thoughtfully and thoroughly by the experts.
AF HANOI and Eurofins GENTIS hope to spread a sense of calm and reassurance to all participating mothers. Therefore, each mother will receive a small gift as a wish for a healthy pregnancy and a gentle, fulfilling motherhood journey.
Event Information
Time: 09:30 – 11:00, Saturday, December 27, 2025
 Venue: 5th Floor Auditorium – Hanoi Hospital of Andrology and Infertility
 Register now: forms.gle/kn6tj49GxxyqjbZy5
 Or scan the QR code in the image to secure your seat early!
Seats are limited to ensure the quality of the class, so expectant mothers are encouraged to register early to avoid missing out.
Eurofins GENTIS – Accompanying mothers through every loving moment
Eurofins GENTIS deeply values every mother’s journey and believes that when mothers are well prepared with knowledge and emotional readiness, pregnancy becomes the most beautiful and peaceful time of life. By partnering with AF HANOI in this prenatal class, GENTIS hopes to bring mothers:


Peace of mind in every decision



Proactive confidence throughout pregnancy



Love that reaches babies from the very first days of life



Throughout a mother’s journey—from preconception, through pregnancy, to early childcare—Eurofins GENTIS is always ready to support with advanced genetic testing solutions, ensuring comprehensive and science-based care for both mother and baby.
In just one morning, mothers gain knowledge, connection, confidence, and love. That is the goal of the prenatal class and the values Eurofins GENTIS wishes to share.
Wishing all mothers a safe, healthy, and happiness-filled pregnancy.
            [content_more] => 
            [meta_title] => Eurofins GENTIS partners with Hanoi hospital of andrology and infertility to host the december prena
            [meta_description] => The journey of pregnancy is a sacred experience, one filled with unique emotions for every mother. It is the overwhelming joy of discovering the presence of a beloved baby, the day-by-day anticipation of feeling those first tiny movements, and at the same
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1392
            [category_id] => 15
        )

    [6] => stdClass Object
        (
            [id] => 1391
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 580472851_1241583017989313_4603897227992683883_n.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-11-12
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-12 14:43:52
            [updated_time] => 2025-12-22 14:48:06
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-congratulates-the-25th-French–Vietnamese-congress-of-obstetrics-and-gynecology-2025-on-its-great-success
            [title] => Eurofins GENTIS congratulates the 25th French–Vietnamese congress of obstetrics and gynecology 2025 on its great success
            [description] => Over two days, November 9–10, 2025, at the National Convention Center, the 25th French–Vietnamese Congress of Obstetrics and Gynecology 2025 jointly organized by the National Hospital of Obstetrics and Gynecology (NHOG) and the French National College of Gynecologists and Obstetricians (CNGOF)—was held with remarkable success. The congress welcomed more than 1,500 delegates, including leading experts, physicians, scientists, and research institutions from Vietnam and abroad. This prestigious scientific event marked over 25 years of strong and enduring collaboration between Vietnam and France in obstetrics and gynecology, reproductive health, and maternal and child care.
            [content] => 
This year’s congress was not only a large-scale academic forum, but also an opportunity for professionals to update the latest knowledge, share practical experience, and foster collaboration aimed at improving the quality of medical care in Vietnam.

Eurofins GENTIS is honored to accompany the congress as a sponsor
As a pioneer in medical genetic testing, Eurofins GENTIS was proud to accompany the 25th Vietnam–France Congress of Obstetrics and Gynecology as a sponsor. Participation in this important event provided a valuable opportunity for GENTIS to reaffirm its position while connecting with the professional community to disseminate modern scientific and technological values to physicians, researchers, and hospitals nationwide.
Amid the growing demand for genetic testing and reproductive support, Eurofins GENTIS is committed to delivering accurate, safe, and rapid testing services to customers and partners, leveraging advanced technologies from the Eurofins Group—one of the world’s leading laboratory networks.
Exhibition Booth – A Highlight of the Congress

At the congress, Eurofins GENTIS introduced a modern exhibition booth and in-depth consultation area, presenting comprehensive solutions in genetics and reproductive medicine. The most highly regarded services included:

Non-Invasive Prenatal Testing (NIPT)
 A solution that analyzes cell-free fetal DNA in maternal blood to enable early detection of chromosomal aneuploidies, ensuring absolute safety for both mother and baby.


Preimplantation Genetic Testing (PGT)
 PGT techniques help select genetically healthy embryos prior to uterine transfer, improving IVF success rates and reducing the risk of inherited diseases.


Genetic Disease Detection and Carrier Screening, Pre-marital and Preconception Counseling
 Designed for couples preparing for marriage or pregnancy, helping to minimize risks associated with recessive genetic disorders.


Andrology Testing and Other Specialized Tests
 Including sperm DNA fragmentation analysis, semen quality assessment, and services supporting infertility and subfertility treatment.



The Eurofins GENTIS booth attracted a large number of congress participants. Many domestic and international experts engaged in direct professional discussions with the GENTIS specialist team. These exchanges opened up valuable collaboration opportunities, promoting broader clinical application of modern genetic technologies in Vietnam.
In addition to its professional exhibits, GENTIS also organized interactive minigames with attractive prizes, creating a lively and friendly atmosphere—an activity warmly welcomed by many delegates.
Supporting the Scientific Presentation by Associate Professor Dr. Trinh The Son
One of the most notable scientific sessions at the congress was the presentation by Associate Professor Dr. Trinh The Son, Director of the Military Institute of Clinical Embryology, entitled “Genetics in Assisted Reproduction: Advances and Future Directions.” Eurofins GENTIS was honored to provide state-of-the-art genetic testing information for this valuable scientific report.

In his presentation, Associate Professor Dr. Trinh The Son highlighted major advances in genetics applied to assisted reproduction, ranging from chromosomal analysis and gene sequencing technologies to optimize embryo selection strategies in IVF.

He particularly emphasized the practical value of advanced tests such as PGT-Next, PGT-Upgrade, WES (Whole Exome Sequencing), and WGS (Whole Genome Sequencing). These techniques are currently implemented by Eurofins GENTIS in accordance with international standards, supporting physicians and patients in achieving higher success rates in infertility treatment.
The presentation received strong attention from the professional community, offering fresh perspectives on trends in applying genetics to modern reproductive medicine.
The Mark of a Successful Congress
After two dynamic working days, the 25th French–Vietnamese Congress of Obstetrics and Gynecology 2025 left a lasting impression. Beyond its academic success with dozens of high-quality scientific presentations, the event demonstrated a strong spirit of international collaboration, promoting exchanges between Vietnamese and French experts toward a shared goal: improving the quality of reproductive healthcare for the community.
The success of the congress stands as clear evidence of the Vietnamese obstetrics and gynecology sector’s continuous efforts to access new knowledge, technologies, and advanced global treatment standards.
Eurofins GENTIS extends its warmest congratulations to the Organizing Committee, experts, speakers, and all delegates who contributed to a vibrant, professional, and meaningful congress. We believe that the values, knowledge, and directions shared at this year’s event will continue to drive the development of obstetrics and gynecology in Vietnam, enabling more families to access advanced, safe, and effective medical solutions.
In the time ahead, Eurofins GENTIS will continue to accompany physicians, hospitals, and assisted reproduction centers nationwide, delivering high-quality testing services that meet international standards—contributing to the enhancement of reproductive health for the Vietnamese community.


            [content_more] => 
            [meta_title] => Eurofins GENTIS congratulates the 25th French–Vietnamese congress of obstetrics and gynecology 2025 
            [meta_description] => Over two days, November 9–10, 2025, at the National Convention Center, the 25th French–Vietnamese Congress of Obstetrics and Gynecology 2025 jointly organized by the National Hospital of Obstetrics and Gynecology (NHOG) and the French National College of 
            [meta_keyword] => GENTIS,Conference
            [thumbnail_alt] => 
            [post_id] => 1391
            [category_id] => 15
        )

    [7] => stdClass Object
        (
            [id] => 1388
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 600x400-web-1.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2025-12-08
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-12-08 09:05:03
            [updated_time] => 2025-12-10 15:48:02
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-participates-in-HASAM-2025-annual-scientific-conference-with-two-in-depth-reports-on-genetics
            [title] => Eurofins GENTIS participates in HASAM 2025 annual scientific conference with two in-depth reports on genetics
            [description] => The demand for reproductive healthcare is rising, and assisted reproductive technologies (ART) continue to advance rapidly. As a result, specialized scientific conferences play a crucial role in updating knowledge, strengthening professional networks, and improving treatment outcomes. The HASAM 2025 Annual Scientific Conference once again affirms its position as one of the most reputable professional events in Vietnam in the field of infertility and reproductive medicine.
            [content] => 
Key highlights
With the theme “Updates on Scientific and Technical Advances to Improve Treatment Outcomes in Infertility”, the conference took place on December 14, 2025, at the National Convention Center (Hanoi), featuring 27 in-depth presentations and the participation of leading experts, doctors, researchers, and representatives from major IVF centers nationwide.

Eurofins GENTIS – a pioneering unit in genetic testing in Vietnam – was honored to accompany the event, aiming to contribute practical scientific value and bring more opportunities to couples hoping to have children.
HASAM 2025 – A prestigious scientific forum for Vietnam’s assisted reproduction field
Over the years, the Annual Scientific Conference of the Hanoi Assisted Reproduction Society (HASAM) has become a meeting place for the IVF community in Vietnam to exchange knowledge, share expertise, and update the latest scientific insights.
This year’s conference places strong emphasis on innovations in assisted reproduction, including:


Policies and development directions for assisted reproduction in Vietnam


Updates on ESHRE 2025 guidelines for ovarian stimulation


Advances in genetic screening, AI applications, and microfluidic technology


Optimization of treatment outcomes and individualized IVF protocols


Population aging and insights from reproductive medicine specialists



The presence of 27 specialized presentations painted a comprehensive picture of the latest scientific trends, contributing to the sustainable, internationally aligned development of ART in Vietnam.
Eurofins GENTIS proudly contributes two in-depth reports at HASAM 2025
As a member of Eurofins Scientific—a global leader in laboratory testing with more than 900 laboratories in 62 countries—Eurofins GENTIS consistently focuses on raising quality standards and developing advanced genetic applications for infertility treatment.

At HASAM 2025, Eurofins GENTIS presented two specialized reports, demonstrating its strong commitment to research and innovation:


Dr. Nguyenn Quang Vinh (Laboratory Director, Eurofins GENTIS): Comprehensive Quality Management of Genetic and Genomic Laboratories in Assisted Reproduction


Dr. Pham Dinh Minh (R&D Director, Eurofins GENTIS): Application of AI and Bioinformatics in Preimplantation Genetic Testing (PGT-AI)




Eurofins GENTIS booth – A space for knowledge exchange and genetic technology
Alongside its presentations, Eurofins GENTIS showcased an engaging exhibition booth that attracted widespread attention from experts and attendees. Visitors were introduced to a comprehensive ecosystem of genetic testing services in:


Assisted Reproduction: PGT-A/SR, PGT-M (100+ rare diseases), PGT-Upgrade, PGT-Next, Karyotype, …


Obstetrics: NIPT, double test, triple test, GEN9, preeclampsia screening,...


Andrology: Sperm DNA fragmentation, AZF testing, CFTR, …


Clinical Genetics: Genetic disease panels, comprehensive gene panels, Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)



The booth also featured an exciting mini-game program with various gifts for delegates visiting the Eurofins GENTIS area. It served as a space for in-depth discussions between Eurofins GENTIS experts and doctors, embryologists, and IVF specialists from centers across the country.
Through this activity, Eurofins GENTIS aims to promote scientific value, share knowledge, and accompany the medical community in improving reproductive healthcare quality in Vietnam.
Commitment to enhancing Vietnamese health and well-being
With the mission “Improving the Intelligence and Physical Well-being of Vietnamese People”, Eurofins GENTIS continuously strives to apply modern technologies in genetic testing to meet the increasing needs of assisted reproduction, providing practical value that helps couples increase their chances of welcoming healthy babies.
Its participation in HASAM 2025 once again reaffirms Eurofins GENTIS's commitment to supporting the medical community, advancing research, and bringing cutting-edge technologies closer to Vietnamese people.
Eurofins GENTIS respectfully invites doctors, experts, and attendees to visit our booth at HASAM 2025 on Sunday, December 14, 2025, at the National Convention Center, Hanoi.
            [content_more] => 
            [meta_title] => Eurofins GENTIS participates in HASAM 2025 annual scientific conference with two in-depth reports on
            [meta_description] => The demand for reproductive healthcare is rising, and assisted reproductive technologies (ART) continue to advance rapidly. As a result, specialized scientific conferences play a crucial role in updating knowledge, strengthening professional networks, and
            [meta_keyword] => GENTIS,Hasam 2025
            [thumbnail_alt] => 
            [post_id] => 1388
            [category_id] => 15
        )

)